Form 4: Cartesian Therapeutics Chief Operations Officer Sells Shares to Cover Tax Obligations

Emily English, Chief Operations Officer of Cartesian Therapeutics, sold a portion of her shares to cover tax obligations related to vesting restricted stock units.

Summary

• Emily English, the Chief Operations Officer of Cartesian Therapeutics, sold 891 shares of common stock on January 3, 2025, at a price of $16.7219 per share.
• She also sold 906 shares of common stock on January 6, 2025, at a price of $16.8322 per share.
• These sales were made to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.
• Following these transactions, Ms. English beneficially owns 40,226 shares of Cartesian Therapeutics common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, with no indication of positive or negative sentiment.

Industry Context

This is a routine filing related to stock sales by a company officer to cover tax obligations, which is a common practice.

Comparison to Industry Standards

• Form 4 filings are standard practice for company insiders when they trade company stock.
• The sale of shares to cover tax obligations is a common occurrence among executives who receive stock-based compensation.
• The transaction is similar to those of other executives at comparable companies who have stock-based compensation.

Stakeholder Impact

• The stock sales by the Chief Operations Officer may have a minor impact on the stock price, but it is unlikely to be significant given the reason for the sale.

Key Dates

Keywords

Cartesian Therapeutics, Emily English, stock sale, insider trading, Form 4, restricted stock units, tax obligations, chief operations officer